Abstract
Keywords:
angiotensins; coronary artery disease; diuretics; obesity; pandemic.
MeSH terms
-
Adrenergic beta-Antagonists / pharmacology
-
Adrenergic beta-Antagonists / therapeutic use
-
Adult
-
Aged
-
Aged, 80 and over
-
Angiotensin Receptor Antagonists / pharmacology
-
Angiotensin Receptor Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / pharmacology
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Antihypertensive Agents / pharmacology*
-
Antihypertensive Agents / therapeutic use
-
COVID-19 / complications
-
COVID-19 / mortality*
-
COVID-19 / physiopathology
-
Female
-
Hospitalization
-
Humans
-
Hypertension / complications
-
Hypertension / drug therapy*
-
Male
-
Middle Aged
-
Renin-Angiotensin System / drug effects*
-
Retrospective Studies
-
SARS-CoV-2
-
Treatment Outcome
-
Withholding Treatment
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents